CIK 0001109354
- Large accelerated filer
BRUKER CORP
Sign in to watch- Ticker
- BRKR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043110160
- Phone
- +1 978-663-3660
- Business address
- 40 MANNING RD, BILLERICA, MA, 01821
- Former names
- BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
Securities
- BRKR Common Stock Nasdaq
- BRKRP 6.375% Mandatory Convertible Preferred Stock, Series A Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $105,740
- in 1 filing
Net −$105,740. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-07 | FURLONG BRENDA J Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2013-01-07 | Fesik Stephen W. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2013-01-07 | Emmerich Wolf-Dieter Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2012-12-14 | LAUKIEN FRANK H CEO/President | Purchase | +50,000 | $14.68 | $734K | 39,159,445 |
| 2012-12-07 | LAUKIEN FRANK H CEO/President | Purchase | +50,000 | $13.97 | $699K | 39,109,445 |
| 2012-09-14 | LAUKIEN JOERG C Director | Purchase | +100,000 | $13.00 | $1.3M | 18,187,755 |
| 2012-09-14 | LAUKIEN FRANK H CEO/President | Purchase | +100,000 | $13.00 | $1.3M | 39,059,445 |
| 2012-08-13 | LAUKIEN FRANK H CEO, President | Grant or award | +100,000 | 38,959,445 | ||
| 2012-08-13 | Prause Burkhard Pres. & CEO, Bruker EST | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-13 | Prause Burkhard Pres. & CEO, Bruker EST | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2012-08-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-13 | LAUKIEN JOERG C Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-13 | VAN INGEN CHRIS Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-13 | FURLONG BRENDA J Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-13 | Emmerich Wolf-Dieter Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-08-02 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award | +88,028 | 88,028 | ||
| 2012-06-25 | VAN INGEN CHRIS Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-05-10 | LAUKIEN FRANK H CEO/President | Exercise or conversion | +25,000 | $13.21 | $330K | 38,859,445 |
| 2012-05-10 | LAUKIEN FRANK H CEO/President | Exercise or conversion | +250,000 | $13.21 | $3.3M | 38,859,445 |
| 2012-05-10 | LAUKIEN FRANK H CEO/President | Exercise or conversion · Stock Option (Right To Buy) | −25,000 | 75,000 |
Page 40 of 54 · 1,078 trades